High-Throughput Discovery of Near-Infrared Oxazine Probes for Fluorescence-Guided Glioblastoma Surgery
Cancers · 19.08.2026 · 18 (16) · 2684
DOI: 10.3390/cancers18162684 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 19.08.2026. Verfasst von Vince Cataldi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Portland, OR 97201, USA. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Oregon Health & Science University, Oregon State University.
Abstract (Originalsprache)
Background/Objectives: Glioblastoma (GBM) is the most aggressive primary malignant brain tumor in adults, characterized by highly infiltrative growth and poorly defined margins that hinder complete surgical resection. Fluorescence-guided surgery (FGS) can enhance intraoperative tumor visualization; however, currently available fluorophores often exhibit limited tumor specificity and inconsistent labeling. This study aimed to identify near-infrared (NIR) probes with improved glioblastoma selectivity using a high-throughput discovery approach.
Methods
A chemically diverse library of 127 NIR oxazine probes was screened using automated fluorescence imaging across four GBM cell lines and a sarcoma control line. Top-performing probes were further evaluated in an orthotopic U251MG-GFP glioblastoma mouse model to assess blood–brain barrier penetration and tumor localization in vivo.
Results
Five candidate probes exhibited strong, selective NIR fluorescence in GBM cells. In vivo imaging revealed that the lead probe, LGW01-44, achieved the highest tumor-to-brain contrast with minimal background signal. Ex vivo analysis of brain sections confirmed preferential accumulation of LGW01-44 within intracranial tumor tissue.
Conclusions
These findings establish a scalable high-throughput platform for the discovery of tumor-selective NIR imaging agents and identify the oxazine probe LGW01-44 as a promising candidate for fluorescence-guided glioblastoma surgery.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Portland, OR 97201, USA.
- Center for Experimental Therapeutics, Oregon Health & Science University, Portland, OR 97239, USA.
- Biomedical Engineering Department, Oregon Health & Science University, Portland, OR 97239, USA.
- Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA.
ORCID-Profile: Vince Cataldi, Dhanir Tailor, Sanjay V Malhotra, Summer L Gibbs, Adam W G Alani
Förderung
- Oregon Health & Science University
- Oregon State University
Zitieren
APA
Cataldi, V., Tailor, D., Montano, A. R., Rizvi, S. Z. H., Chakraborty, S., Saldivar, J. C., Malhotra, S. V., Wang, L. G., Gibbs, S. L., & Alani, A. W. G. (2026). High-Throughput Discovery of Near-Infrared Oxazine Probes for Fluorescence-Guided Glioblastoma Surgery. Cancers, 18(16), 2684. https://doi.org/10.3390/cancers18162684
Vancouver
Cataldi V, Tailor D, Montano AR, Rizvi SZH, Chakraborty S, Saldivar JC, et al. High-Throughput Discovery of Near-Infrared Oxazine Probes for Fluorescence-Guided Glioblastoma Surgery. Cancers. 2026;18(16):2684. doi:10.3390/cancers18162684
BibTeX
@article{Cataldi2026,
author = {Cataldi, Vince and Tailor, Dhanir and Montano, Antonio R and Rizvi, Syed Zaki Husain and Chakraborty, Samrat and Saldivar, Joshua C and Malhotra, Sanjay V and Wang, Lei G and Gibbs, Summer L and Alani, Adam W G},
title = {High-Throughput Discovery of Near-Infrared Oxazine Probes for Fluorescence-Guided Glioblastoma Surgery},
journal = {Cancers},
year = {2026},
volume = {18},
number = {16},
pages = {2684},
doi = {10.3390/cancers18162684}
}
EUVIMED